Cargando…

Estimating the Fitness Advantage Conferred by Permissive Neuraminidase Mutations in Recent Oseltamivir-Resistant A(H1N1)pdm09 Influenza Viruses

Oseltamivir is relied upon worldwide as the drug of choice for the treatment of human influenza infection. Surveillance for oseltamivir resistance is routinely performed to ensure the ongoing efficacy of oseltamivir against circulating viruses. Since the emergence of the pandemic 2009 A(H1N1) influe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Butler, Jeff, Hooper, Kathryn A., Petrie, Stephen, Lee, Raphael, Maurer-Stroh, Sebastian, Reh, Lucia, Guarnaccia, Teagan, Baas, Chantal, Xue, Lumin, Vitesnik, Sophie, Leang, Sook-Kwan, McVernon, Jodie, Kelso, Anne, Barr, Ian G., McCaw, James M., Bloom, Jesse D., Hurt, Aeron C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974874/ https://www.ncbi.nlm.nih.gov/pubmed/24699865 http://dx.doi.org/10.1371/journal.ppat.1004065

Ejemplares similares

Reducing Uncertainty in Within-Host Parameter Estimates of Influenza Infection by Measuring Both Infectious and Total Viral Load
por: Petrie, Stephen M., et al.
Publicado: (2013)

Correction: Reducing Uncertainty in Within-Host Parameter Estimates of Influenza Infection by Measuring Both Infectious and Total Viral Load
por: Petrie, Stephen M., et al.
Publicado: (2013)

Reducing disease burden in an influenza pandemic by targeted delivery of neuraminidase inhibitors: mathematical models in the Australian context
por: Moss, Robert, et al.
Publicado: (2016)

Evaluation of oseltamivir prophylaxis regimens for reducing influenza virus infection, transmission and disease severity in a ferret model of household contact
por: Oh, Ding Yuan, et al.
Publicado: (2014)

Predicting Permissive Mutations That Improve the Fitness of A(H1N1)pdm09 Viruses Bearing the H275Y Neuraminidase Substitution
por: Farrukee, Rubaiyea, et al.
Publicado: (2022)

Antigenic Drift of the Pandemic 2009 A(H1N1) Influenza Virus in a Ferret Model
por: Guarnaccia, Teagan, et al.
Publicado: (2013)

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
por: Leang, Sook-Kwan, et al.
Publicado: (2017)

A Mathematical Framework for Estimating Pathogen Transmission Fitness and Inoculum Size Using Data from a Competitive Mixtures Animal Model
por: McCaw, James M., et al.
Publicado: (2011)

Progressive emergence of an oseltamivir‐resistant A(H3N2) virus over two courses of oseltamivir treatment in an immunocompromised paediatric patient
por: Hurt, Aeron C., et al.
Publicado: (2013)

Mutations I117V and I117M and Oseltamivir Sensitivity of Pandemic (H1N1) 2009 Viruses
por: Hurt, Aeron C., et al.
Publicado: (2012)

Innate Immunity and the Inter-exposure Interval Determine the Dynamics of Secondary Influenza Virus Infection and Explain Observed Viral Hierarchies
por: Cao, Pengxing, et al.
Publicado: (2015)

Interval Between Infections and Viral Hierarchy Are Determinants of Viral Interference Following Influenza Virus Infection in a Ferret Model
por: Laurie, Karen L., et al.
Publicado: (2015)

Impact of Emerging Antiviral Drug Resistance on Influenza Containment and Spread: Influence of Subclinical Infection and Strategic Use of a Stockpile Containing One or Two Drugs
por: McCaw, James M., et al.
Publicado: (2008)

Diagnosis and Antiviral Intervention Strategies for Mitigating an Influenza Epidemic
por: Moss, Robert, et al.
Publicado: (2011)

Pertussis models to inform vaccine policy
por: Campbell, Patricia T, et al.
Publicado: (2015)

A Biological Model for Influenza Transmission: Pandemic Planning Implications of Asymptomatic Infection and Immunity
por: Mathews, John D., et al.
Publicado: (2007)

Characterization of Influenza B Virus Variants with Reduced Neuraminidase Inhibitor Susceptibility
por: Farrukee, R., et al.
Publicado: (2018)

Characteristics of a Widespread Community Cluster of H275Y Oseltamivir-Resistant A(H1N1)pdm09 Influenza in Australia
por: Hurt, A. C., et al.
Publicado: (2012)

Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza
por: Hurt, Aeron C., et al.
Publicado: (2016)

Seroprevalence of antibody to influenza A(H1N1)pdm09 attributed to vaccination or infection, before and after the second (2010) pandemic wave in Australia
por: McVernon, Jodie, et al.
Publicado: (2014)

Understanding influenza transmission, immunity and pandemic threats
por: Mathews, John D., et al.
Publicado: (2009)

Peramivir and laninamivir susceptibility of circulating influenza A and B viruses
por: Leang, Sook-Kwan, et al.
Publicado: (2014)

TaqMan real time RT-PCR assays for detecting ferret innate and adaptive immune responses
por: Carolan, Louise A., et al.
Publicado: (2014)

Model answers or trivial pursuits? The role of mathematical models in influenza pandemic preparedness planning
por: McVernon, J, et al.
Publicado: (2007)

Dynamical crises, multistability and the influence of the duration of immunity in a seasonally-forced model of disease transmission
por: Dafilis, Mathew P, et al.
Publicado: (2014)

Infectious disease pandemic planning and response: Incorporating decision analysis
por: Shearer, Freya M., et al.
Publicado: (2020)

Prior immunity helps to explain wave-like behaviour of pandemic influenza in 1918-9
por: Mathews, John D, et al.
Publicado: (2010)

Prior Population Immunity Reduces the Expected Impact of CTL-Inducing Vaccines for Pandemic Influenza Control
por: Bolton, Kirsty J., et al.
Publicado: (2015)

Understanding mortality in the 1918–1919 influenza pandemic in England and Wales
por: Pearce, Dora C., et al.
Publicado: (2010)

A modelling approach to estimate the transmissibility of SARS-CoV-2 during periods of high, low, and zero case incidence
por: Golding, Nick, et al.
Publicado: (2023)

Rapid assessment of the risk of SARS-CoV-2 importation: case study and lessons learned
por: Shearer, Freya M., et al.
Publicado: (2022)

Oseltamivir-resistant influenza A(H1N1)pdm2009 strains found in Brazil are endowed with permissive mutations, which compensate the loss of fitness imposed by antiviral resistance
por: Souza, Thiago Moreno Lopes e, et al.
Publicado: (2015)

COVID-19 in low-tolerance border quarantine systems: Impact of the Delta variant of SARS-CoV-2
por: Zachreson, Cameron, et al.
Publicado: (2022)

I223R Mutation in Influenza A(H1N1)pdm09 Neuraminidase Confers Reduced Susceptibility to Oseltamivir and Zanamivir and Enhanced Resistance with H275Y
por: LeGoff, Jérome, et al.
Publicado: (2012)

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016–2017
por: Lackenby, Angie, et al.
Publicado: (2018)

Influence of Contact Definitions in Assessment of the Relative Importance of Social Settings in Disease Transmission Risk
por: Bolton, Kirsty J., et al.
Publicado: (2012)

Factors associated with transmission of influenza-like illness in a cohort of households containing multiple children
por: Brown, Chelsea R, et al.
Publicado: (2015)

Assessing the susceptibility of highly pathogenic avian influenza H5N1 viruses to oseltamivir using embryonated chicken eggs
por: Tare, Deeksha S., et al.
Publicado: (2019)

Comparison of three methods for ascertainment of contact information relevant to respiratory pathogen transmission in encounter networks
por: McCaw, James M, et al.
Publicado: (2010)

Utilising animal models to evaluate oseltamivir efficacy against influenza A and B viruses with reduced in vitro susceptibility
por: Farrukee, Rubaiyea, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j5joa28kpnv92q4vujr1i3r37n